| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc. (OTCEM:SYRS) through any online brokerage.
There are no as such competitors for SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc..
SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc. has a consensus price target of $3.00.
The stock price for SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc. (OTCEM: SYRS) is $0.0004 last updated October 12, 2026 at 1:30 PM EDT.
There are no upcoming dividends for SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc..
SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc..
SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.
